Publications by authors named "William D Tap"

Claim this Profile
A
Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapy.
Kristine H Jang, Joseph S Wallins, I-Hsin Lin, Sujana Movva, William D Tap

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.
Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, Jasme Lee, Mathew Adamow, William D Tap

Cancer Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.
Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga, William D Tap

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-Learning Tool ScVital Enables Species-Agnostic Integration of Cancer Cell States.
Jonathan Rub, Jason E Chan, Carleigh Sussman, Gary Guzman, William D Tap

Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum.
Kelsey E Breen, Nikita Mehta, Vignesh Ravichandran, Miika Mehine, Chuan Gao, William D Tap

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.
Ciara M Kelly, Martina Bradic, Sara Saunds, Viswatej Avutu, Lauren Banks, William D Tap

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, Allison L Richards, Ciara M Kelly, William D Tap

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Acupuncture and Massage on Pain in Adolescent and Young Adult Patients with Advanced Cancer: Subgroup Analysis of a Randomized Clinical Trial.
Han-Wei V Wu, Xiaotong Li, Qing S Li, Raymond E Baser, Katherine S Panageas, William D Tap

J Adolesc Young Adult Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma.
Yamato Suemitsu, Hsin-Yi Chang, Carla Saoud, Josephine K Dermawan, Meera Hameed, William D Tap

Genes Chromosomes Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study.
Andrew J Wagner, William D Tap, Sebastian Bauer, Jean-Yves Blay, Jayesh Desai

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.
William D Tap, Gregory M Cote, Howard Burris, Lia Gore, Anthony Elias

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma.
Sandra P D'Angelo, Mihaela Druta, Brian A Van Tine, David Liebner, Scott M Schuetze, William D Tap

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas.
Carla Saoud, Josephine K Dermawan, Kanika Arora, William D Tap, Damon Reed

NPJ Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, Michael V Ortiz, Viswatej Avutu, William D Tap

JCO Oncol Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade.
Olayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, Martina Bradic, Bernard O'Malley, William D Tap

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies.
Daniel Reinhorn, Mor Moskovitz, William D Tap, Bob T Li

Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of the Upfront Osteosarcoma Treatment Paradigm for Adolescents and Young Adults.
Nicole P Daukshus, Viswatej Avutu, Emily Long Sarro, Michael D Kinnaman, Emily K Slotkin, William D Tap

J Adolesc Young Adult Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib.
Jayesh Desai, Andrew J Wagner, Irene Carrasco Garcia, Marilena Cesari, Michael Gordon, William D Tap

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Sujana Movva, Kenneth Seier, Viswatej Avutu, Lauren B Banks, Jason Chan, William D Tap

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.
Silvia Stacchiotti, Silvia Martini, Sandro Pasquali, Anna M Frezza, Alessia Beretta, William D Tap

Clin Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations.
Josephine K Dermawan, David H Abramson, Sarah Chiang, Martee L Hensley, William D Tap

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.
Benjamin A Nacev, Yakshi Dabas, Matthew R Paul, Christian Pacheco, Michelle Mitchener, William D Tap

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib.
Hans Gelderblom, Albiruni A Razak, Matthew H Taylor, Todd M Bauer, Breelyn Wilky, William D Tap

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses.
Nathan D Seligson, James L Chen, Austin C Goodrich, Brian A Van Tine, Jordan D Campbell, William D Tap

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretable artificial intelligence to optimise use of imatinib after resection in patients with localised gastrointestinal stromal tumours: an observational cohort study.
Dimitris Bertsimas, Georgios Antonios Margonis, Suleeporn Sujichantararat, Angelos Koulouras, Yu Ma, William D Tap

Lancet Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis